The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis
NCT ID: NCT06088485
Last Updated: 2023-11-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
60 participants
OBSERVATIONAL
2023-09-05
2024-02-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Upper Extremity Exercise Capacity, Muscle Oxygenation, Balance in Patients With Cystic Fibrosis
NCT04803643
Assessment of Cognitive Function and Exercise Capacity in Cystic Fibrosis
NCT06175182
A Comparison of Clinical Parameters in With and Without Abnormal Glucose Tolerance.
NCT04503408
Development a Core Set for Adults With Cystic Fibrosis Based on the ICF
NCT06128499
Reaction Time and Postural Control in Individuals With Cystic Fibrosis and Bronchiectasis
NCT03902236
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
low bone mineral density
bone mineral density according to t and z score.
No interventions assigned to this group
normal bone mineral density
bone mineral density according to t and z score.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* who had a fracture in any part of the patient's body
* who had undergone spine surgery
* who had an orthopedic, neurological or metastatic history in addition to Cystic Fibrosis
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hacettepe University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aynur Demirel
PT, PhD, Assoc. Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aynur Demirel
Role: PRINCIPAL_INVESTIGATOR
Hacettepe University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hacettepe University, Health Sciences Faculty
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GO22/126
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.